Login / Signup

Post-implantation clinical cost analysis between transcutaneous and percutaneous bone conduction devices.

Tjerk W AukemaEmma M TeunissenArno M JanssenMyrthe Karianne Sophie HolEmmanuel A M Mylanus
Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
Total costs related to post-operative rehabilitation and treatments are comparable between percutaneous and transcutaneous BCDs up to 5 years after implantation. Complications related to passive transcutaneous bone conduction devices appeared significantly more expensive after implantation due to more frequent explantations.
Keyphrases
  • bone mineral density
  • minimally invasive
  • ultrasound guided
  • soft tissue
  • radiofrequency ablation
  • bone loss
  • risk factors
  • postmenopausal women
  • bone regeneration
  • drug induced